Product Program year 2023 Source: CMS Open Payments

Omnis

Device Immunohistochemistry (IHC) and in Situ Hybridization Platform

Open in the dashboard

General payments

$79,331

21 payments

Research payments

$0

0 payments

Through program year 2023, $79,331 in general payments and $0 in research payments were reported against Omnis (Immunohistochemistry (IHC) and in Situ Hybridization Platform).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2023 General $79,331 21

Breakdown

Who paid General payments · program year 2023
  1. Agilent Technologies, Inc. $79,331 21 payments
Top recipients General payments · program year 2023
  1. Serge Alexanian Anatomic Pathology & Clinical Pathology · Los Angeles, CA $71,873 91% · 5 payments
  2. John Blaustein Anatomic Pathology & Clinical Pathology · Santa Barbara, CA $6,019 8% · 3 payments
  3. Regina Patricia Singson Anatomic Pathology & Clinical Pathology · Thousand Oaks, CA $559 <1% · 4 payments
  4. Mohammed Shrit Anatomic Pathology & Clinical Pathology · Dayton, OH $408 <1% · 5 payments
  5. Simon Warren Dermatopathology · Ann Arbor, MI $134 <1% · 1 payment

The top 5 of 8 recipients; each share is of general payments naming this product in 2023.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2023
  1. Anatomic Pathology & Clinical Pathology Pathology $79,197 100% · 7 practitioners
  2. Dermatopathology Pathology $134 <1% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2023. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2023
  1. California $78,532 99% · 4 recipients
  2. Ohio $408 <1% · 1 recipient
  3. Indiana $268 <1% · 2 recipients
  4. Michigan $123 <1% · 1 recipient

Each share is of general payments naming this product in 2023 where a state was reported.

21 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2023

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record